Evaluate is the trusted provider of commercial intelligence including product sales and consensus forecasts to 2022 for commercial teams and their advisors within the global life science industry.
We help our clients make high value decisions through superior quality, timely, must-have data, insights, combined with personalised, expert client support.
Our online subscription services cover the pharmaceutical, biotech and medtech sectors. Our Custom Services group delivers project based analytical and data services.
Vantage, our independent, award-winning editorial team, offers data-driven, forward-looking news, commentary and analysis on a daily basis.
For more information visit www.evaluate.com. On Twitter: @Evaluatepharma, @EPVantage
Evaluate Ltd has its global headquarters in London, England. In North America, EvaluatePharma is represented by EvaluatePharma USA, Inc., based in Boston, MA.
EvaluatePharma USA, Inc
15 Broad Street, Ste 401
Boston, MA 02109
- Company Name:Evaluate Ltd
(View Trends)
-
Headquarters: (View Map)London, United Kingdom
-
Information Services
-
50 - 200 employees
- 258346 Global Rank
- 117353 United States
- 199 K Estimated Visits
-
Search48.36%
-
Direct40.75%
-
Referrals5.54%
-
Social3.79%
-
Mail1.38%
-
Display0.17%
-
40.68%
-
22.40%
-
4.60%
-
3.63%
-
Native1.39%
-
Standard80.56%
-
Direct18.06%
They are headquartered at London, United Kingdom, and have 2 advertising & marketing contacts listed on Kochava. Evaluate Ltd works with Advertising technology companies such as DoubleClick.Net, Google Remarketing, Facebook Custom Audiences, LinkedIn Ads, DoubleClick Bid Manager, Google Floodlight Counter, Twitter Ads, The Trade Desk, AppNexus, Advertising.com, BlueKai DMP, IntentIQ, BlueKai, eXelate, Drawbridge, Tapad, Eyeota, AOL-Time Warner Online Advertising, Rubicon Project, Google Adsense, Affectv, OnAudience, FLoC Opt-Out, FLoC.
